ARMO BioSciences, Inc.

ARMO BioSciences, Inc.

ARMO BioSciences, Inc.

Overview
Date Founded

2010

Headquarters

575 Chesapeake Drive,Redwood, CA 94063

Type of Company

Private

Employees (Worldwide)

31

Industries

Pharmaceuticals
Hospitals & Patient Services
Biotechnology

Company Description

ARMO BioSciences, Inc. develops immunotherapy for the treatment of cancer, cardiovascular diseases, fibrosis, and inflammation. Its lead product candidate is AM0010 (pegilodecaki). The company was founded by Peter Van Vlasselaer, Martin Oft, and John B. Mumm on June 23, 2010 and is headquartered in Redwood, CA.

Contact Data
Trying to get in touch with decision makers at ARMO BioSciences, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
In The News
Executives & Employees

Founder

President & Director

Vice President, Technical Operations

Vice President, Corporate Development

Vice President-Operations & Corporate Development

Secretary

Senior Director

Treasurer, Director & Vice President

Vice President Corporate Development

Contract Senior Clinical Trial Manager

Board of Directors

Chief Audit Executive at Eli Lilly & Company

President & Director at ARMO BioSciences, Inc.

Treasurer, Director & Vice President at ARMO BioSciences, Inc.

Paths to ARMO BioSciences, Inc.
Potential Connections via
Relationship Science
You
ARMO BioSciences, Inc.
Recent Transactions
Details Hidden

Eli Lilly & Company purchases ARMO BioSciences, Inc.

Details Hidden

ARMO BioSciences, Inc. issued USD Common Stock

Transaction Advisors
Investment Advisor

Advised onEli Lilly & Company purchases ARMO BioSciences, Inc.

Underwriter

Advised onARMO BioSciences, Inc. issued USD Common Stock

Investment Advisor

Advised onEli Lilly & Company purchases ARMO BioSciences, Inc.

Associate

Advised onEli Lilly & Company purchases ARMO BioSciences, Inc.

Legal Advisor

Advised onEli Lilly & Company purchases ARMO BioSciences, Inc.

Legal Advisor

Advised onEli Lilly & Company purchases ARMO BioSciences, Inc.

Key Stats and Financials As of 2017
Market Capitalization
$1.52B
Total Enterprise Value
Earnings Per Share
Revenue
$0
EBITDA
$-42.5M
Investors
Details Hidden
Details Hidden

Qiming is a China-focused venture capital investment manager with a long-term outlook, who pays limited attention to short-term ups and downs. The firm invests in early-stage and select expansion-stage companies in sectors including healthcare, technology, semiconductors, material science, media, Internet, telecommunications, consumer products, retail and clean technology. They seek to invest in businesses with strong management teams, positioned in high-growth markets. Their main investment themes are servicing the large domestic market in China as well as the robust export sector.

Details Hidden

Sequoia Capital invests in seed to early stage companies. The firm focuses on energy, financial services, healthcare, Internet, mobile and technology sectors. Within the energy sector, the firm seeks to partner with start-ups focused on the alternative energy, conventional energy, energy efficiency, energy storage and energy services markets.

Suppliers
Merck & Co., Inc. Medical Support Services | Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Competitors
Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Bristol-Myers Squibb Company Pharmaceuticals - New York, New York

Bristol-Myers Squibb Company Our company has a strong legacy of innovation that began in New York in 1858 when Edward R. Squibb, M.D., founded a pharmaceutical company in Brooklyn, and in 1887 when two friends, William McLaren Bristol and John Ripley Myers purchased a struggling drug manufacturing firm in Clinton. Together, they laid the foundation for our company today — a global BioPharma leader that continues this legacy of innovation.

Roche Holding AG Pharmaceuticals - Basel, BS

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by ARMO BioSciences, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of ARMO BioSciences, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and ARMO BioSciences, Inc..